#pmda — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #pmda, aggregated by home.social.
-
https://www.europesays.com/britain/43819/ Japan expands GSK Arexvy RSV vaccine approval to adults 18-49 #Arexvy #ChronicDiseasePrevention #ClinicalTrials #GSK #HealthcareRegulatoryApproval #JapanMHLW #PharmaceuticalMarket #PMDA #RespiratorySyncytialVirus #RSVVaccine
-
https://www.alojapan.com/1377606/varmx-receives-phase-1-waiver-from-japanese-regulator-pmda/ VarmX receives Phase 1 waiver from Japanese regulator PMDA #biotech #DrugDevelopment #Japan #JapanNews #Japanese #JapaneseNews #news #Phase3 #PMDA #VarmXB.V. VarmX receives Phase 1 waiver from Japanese regulator PMDA for lead asset VMX-C001 Japanese regulator, the PMDA, waived the requirement for a Phase 1 trial in Japanese subjects for lead asset VMX-C001, enabling it to go straight to Phase 3 developmentRare waiver recognizes the global dat
-
https://www.alojapan.com/1377606/varmx-receives-phase-1-waiver-from-japanese-regulator-pmda/ VarmX receives Phase 1 waiver from Japanese regulator PMDA #biotech #DrugDevelopment #Japan #JapanNews #Japanese #JapaneseNews #news #Phase3 #PMDA #VarmXB.V. VarmX receives Phase 1 waiver from Japanese regulator PMDA for lead asset VMX-C001 Japanese regulator, the PMDA, waived the requirement for a Phase 1 trial in Japanese subjects for lead asset VMX-C001, enabling it to go straight to Phase 3 developmentRare waiver recognizes the global dat
-
VarmX receives Phase 1 waiver from Japanese regulator PMDA
VarmX receives Phase 1 waiver from Japanese regulator PMDA for lead asset VMX-C001 Japanese regulator, the PMDA, waived the requirement for a Phase 1 trial in Japanese subjects for lead asset VMX-C001, enabling it to go straight to Phase 3 dev…
#Japan #JP #JapanNews #biotech #drugdevelopment #Japanese #Japanesenews #news #Phase3 #PMDA #VarmXB.V.
https://www.alojapan.com/1377606/varmx-receives-phase-1-waiver-from-japanese-regulator-pmda/ -
VarmX receives Phase 1 waiver from Japanese regulator PMDA
VarmX receives Phase 1 waiver from Japanese regulator PMDA for lead asset VMX-C001 Japanese regulator, the PMDA, waived the requirement for a Phase 1 trial in Japanese subjects for lead asset VMX-C001, enabling it to go straight to Phase 3 dev…
#Japan #JP #JapanNews #biotech #drugdevelopment #Japanese #Japanesenews #news #Phase3 #PMDA #VarmXB.V.
https://www.alojapan.com/1377606/varmx-receives-phase-1-waiver-from-japanese-regulator-pmda/